Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluating intravenous ferric carboxymaltose for treating anemia in cancer patients undergoing chemotherapy, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: King Hussein Cancer Center | Conditions: Anemia, Cancer | NA | Status: COMPLETED | Results posted: 2021-12-08